JCR Pharmaceuticals CoJCRRF 65 Dividend Yield % is 3.96% as of Jun. 26, 2026, which is 414% above its 10-year median of 0.77. GuruFocus rates JCRRF with a GF Score™ of 65/100 and a GF Value™ of $4.97 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 516 Drug Manufacturers companies, JCR Pharmaceuticals Co ranks better than 82.75% on this metric.
As of today (2026-06-26), the Trailing Annual Dividend Yield of JCR Pharmaceuticals Co is 3.96%.
Good Sign:
JCR Pharmaceuticals Co Ltd stock Dividend Yield % is close to 10-year high.
The historical rank and industry rank for JCR Pharmaceuticals Co's Dividend Yield % or its related term are showing as below:
JCRRF'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.25 Med: 0.77 Max: 4.75
Current: 3.96
During the past 13 years, the highest Dividend Yield of JCR Pharmaceuticals Co was 4.75%. The lowest was 0.25%. And the median was 0.77%.
JCRRF's Dividend Yield % is ranked better than 82.75% of 516
companies
in the Drug Manufacturers industry
Industry Median: 2.03
vs JCRRF: 3.96
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of JCR Pharmaceuticals Co Ltd is 4.50, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of JCR Pharmaceuticals Co was 5.88. The lowest was 0.16. And the median was 0.39.
During the past 5 years, the average Dividends Per Share Growth Rate was 12.80% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 20.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of JCR Pharmaceuticals Co was 51.30% per year. The lowest was -3.90% per year. And the median was 15.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
JCR Pharmaceuticals Co (OTCPK:JCRRF) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
JCR Pharmaceuticals Co Dividend Yield % Related Terms
JCR Pharmaceuticals Co Dividend Yield % Historical Data
* Premium members only.
The historical data trend for JCR Pharmaceuticals Co's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JCRRF vs LLY, JNJ, ABBV: Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JCR Pharmaceuticals Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where JCR Pharmaceuticals Co's Dividend Yield % falls into.
JCR Pharmaceuticals Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
JCR Pharmaceuticals Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 10.000000
2026-03-31
2026-03-31
2026-06-24
Cash Dividend
semi-annually
JPY:USD 0.006286
JPY 10.000000
2026-03-30
2026-03-31
0000-00-00
Cash Dividend
semi-annually
JPY:USD 0.006286
JPY 10.000000
2025-09-29
2025-09-30
2025-12-05
Cash Dividend
semi-annually
JPY:USD 0.006758
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JCR Pharmaceuticals Co (JCRRF) has a Dividend Yield % of 3.96% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on JCR Pharmaceuticals Co and its competitors. This is 414% above median its historical median of 0.77. Over the past decade, JCR Pharmaceuticals Co's Dividend Yield % has ranged from 0.25 to 4.75. According to the industry distribution chart, JCR Pharmaceuticals Co ranks #89 out of 516 companies in the Drug Manufacturers industry, placing it in the top 17.2%.
Is JCR Pharmaceuticals Co's Dividend Yield % too high?
JCR Pharmaceuticals Co's current Dividend Yield % of 3.96% is 414% above median its 10-year median of 0.77. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 4.75. The Drug Manufacturers industry median Dividend Yield % is 2.03. JCR Pharmaceuticals Co's value of 3.96% is 95.1% above this industry median. Based on the distribution chart, JCR Pharmaceuticals Co ranks #89 out of 516 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, JCR Pharmaceuticals Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, JCR Pharmaceuticals Co ranks #89 out of 516 companies for Dividend Yield %. This places JCR Pharmaceuticals Co in the top 17% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.03. JCR Pharmaceuticals Co's value of 3.96% is 95.1% above this benchmark. Historically, JCR Pharmaceuticals Co's own Dividend Yield % has ranged from 0.25 to 4.75 over the past decade. While the company's 10-year median is 0.77 vs. the industry median of 2.03, JCR Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.03, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JCR Pharmaceuticals Co's current Dividend Yield % of 3.96% is 95.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on JCR Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JCR Pharmaceuticals Co's current Dividend Yield % is 3.96%, which is 414% above median its own 10-year median of 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (JCRRF) is currently considered Possible Value Trap. The stock's GF Value™ is $4.97, compared to a current price of $3.15 — trading 36.7% below its estimated fair value. The current Dividend Yield % is 3.96%, which is 414% above median its 10-year median of 0.77 and 95.1% above the Drug Manufacturers industry median of 2.03. JCR Pharmaceuticals Co's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For JCR Pharmaceuticals Co (JCRRF), the current Dividend Yield % is 3.96% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JCR Pharmaceuticals Co (JCRRF) Overvalued in 2026?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued.
The current stock price of $3.15 is trading 36.7% below its estimated GF Value™ of $4.97.
GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.
Key valuation signals for JCRRF:
Dividend Yield %: 3.96% (414% above median its 10-year median of 0.77)
GF Value™: $4.97 vs. price of $3.15 (36.7% below fair value)
Industry Position: 95.1% above the Drug Manufacturers median (#89 of 516)
No single metric tells the full story. See the JCRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
65GF Score
Get the complete analysis for JCRRF
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JCRRF has been successfully added to your 
